Tag: Destiny-Breast03
FDA Approves Trastuzumab Deruxtecan for Adult Patients with Unresectable or Metastatic...
The U.S. Food and Drug Administration (FDA) has approved fam-trastuzumab deruxtecan-nxki (Enhertu®; Daiichi Sankyo and AstraZeneca) for the treatment of adult patients with unresectable or metastatic HER2...
World ADC London 2022: What to Expect
With World ADC London staring later this week, excitement is building for the first in-person event in two years, with virtual attendance options available! With 70+ speakers...
